The ED-AWARENESS-2 Trial

NARecruitingINTERVENTIONAL
Enrollment

3,090

Participants

Timeline

Start Date

June 28, 2023

Primary Completion Date

March 1, 2027

Study Completion Date

September 1, 2027

Conditions
AwarenessMechanical VentilationIntubation ComplicationPTSD
Interventions
OTHER

Standard neuromuscular blocker practices

Usual care neuromuscular blocker in the ED

BEHAVIORAL

Education

Nurses and physicians will be engaged regarding the clinical outcome data on the importance of shorter acting neuromuscular blockers, and the objectives of the research. Education will include in-services and lectures focused on the importance of neuromuscular blocker protocols on patient outcome. The use of neuromuscular blokers will be evaluated throughout the study in order to better understand providers' perception of and experience with ED-based neuromuscular blocker protocols.

Trial Locations (4)

52242

RECRUITING

Roy J. and Lucille A. Carver College of Medicine, Iowa City

55415

RECRUITING

Hennepin Healthcare, Minneapolis

98195

RECRUITING

University of Washington School of Medicine, Seattle

08103

RECRUITING

Cooper University Hospital/Cooper Medical School of Rowan University, Camden

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Washington University School of Medicine

OTHER